← Back to all trials
Recruiting
NCT07742982
Efficacy of Topical Tyrosine Versus Topical 5-Fluorouracil With Fractional Erbium YAG Laser
Conditions: Focal Vitiligo
Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Phase: EARLY_PHASE1
Enrollment: 40
Sponsor: Aswan University
Location: Aswan University Hospital Aswān
Summary
Vitiligo is an autoimmune disorder affecting the skin, specifically targeting pigment-producing melanocytes, leading to noticeable regions of depigmentation characterized by white spots.
It is a widely prevalent skin disorder globally, affecting males and females almost equally, although it is reported slightly more frequently in females. In more than 60% of patients, the disease begins before the age of 30 and It has an estimated prevalence of roughly 0.2-2% across various populations, with around 0.4% in the European-derived white (EUR) population.
Eligibility Criteria
Inclusion Criteria:
\- Patients with focal vitiligo
Exclusion Criteria:
* Pregnancy.
* Lactation.
* Patients with segmental vitiligo.
* Patients with autoimmune disease including thyroiditis.
* Patients with chronic systemic diseases,such as anemia ,diabetes mellitus, immunosuppression, or chronic infections.
* Patients with active skin infections.
Source: ClinicalTrials.gov (NCT07742982). StuddyBuddy aggregates publicly available trial information.